Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4

Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4

Antimitotic drugs that target tubulin are among the most widely used chemotherapeutic agents; however, the development of multidrug resistance has limited their clinical activity. We report the synthesis and biological properties of a series of novel 3-chloro-β-lactams and 3,3-dichloro-β-lactams (2-...

Full description

Bibliographic Details
Main Authors:	Azizah M. Malebari, Shu Wang, Thomas F. Greene, Niamh M. O’Boyle, Darren Fayne, Mohemmed Faraz Khan, Seema M. Nathwani, Brendan Twamley, Thomas McCabe, Daniela M. Zisterer, Mary J. Meegan
Format:	Article
Language:	English
Published:	MDPI AG 2021-10-01
Series:	Pharmaceuticals
Subjects:	β-lactam 3-chloroazetidin-2-ones antimitotic antiproliferative activity breast cancer tubulin polymerisation
Online Access:	https://www.mdpi.com/1424-8247/14/11/1119

Similar Items

3-Vinylazetidin-2-Ones: Synthesis, Antiproliferative and Tubulin Destabilizing Activity in MCF-7 and MDA-MB-231 Breast Cancer Cells
by: Shu Wang, et al.
Published: (2019-04-01)

Synthesis, Characterisation and Mechanism of Action of Anticancer 3-Fluoroazetidin-2-ones
by: Azizah M. Malebari, et al.
Published: (2022-08-01)

Synthesis and Biological Evaluation of Novel 3-Isopropenyl-β-Lactams: Heterocyclic Bridged Analogues of Combretastatin A-4 as Novel Antimitotic Agents in Breast Cancer
by: Azizah Malebari, et al.
Published: (2022-11-01)

Synthesis and Biological Evaluation of 1-(Diarylmethyl)-1<i>H</i>-1,2,4-triazoles and 1-(Diarylmethyl)-1<i>H</i>-imidazoles as a Novel Class of Anti-Mitotic Agent for Activity in Breast Cancer
by: Gloria Ana, et al.
Published: (2021-02-01)

Synthesis and Biological Evaluation of New <i>cis</i>-Restricted Triazole Analogues of Combretastatin A-4
by: Lidia Prieto, et al.
Published: (2025-01-01)

Viriditoxin Stabilizes Microtubule Polymers in SK-OV-3 Cells and Exhibits Antimitotic and Antimetastatic Potential
by: Mingzhi Su, et al.
Published: (2020-08-01)

Potent and Selective Benzothiazole-Based Antimitotics with Improved Water Solubility: Design, Synthesis, and Evaluation as Novel Anticancer Agents
by: Laura Gallego-Yerga, et al.
Published: (2023-06-01)

Design, synthesis and biological evaluation of novel thiazole-naphthalene derivatives as potential anticancer agents and tubulin polymerisation inhibitors
by: Guangcheng Wang, et al.
Published: (2021-01-01)

(<i>E</i>)-1-(3-(3-Hydroxy-4-Methoxyphenyl)-1-(3,4,5-Trimethoxyphenyl)allyl)-1<i>H</i>-1,2,4-Triazole and Related Compounds: Their Synthesis and Biological Evaluation as Novel Antimitotic Agents Targeting Breast Cancer
by: Gloria Ana, et al.
Published: (2025-01-01)

Potent hemithioindigo-based antimitotics photocontrol the microtubule cytoskeleton in cellulo
by: Alexander Sailer, et al.
Published: (2020-01-01)

Design, synthesis and molecular docking of novel diarylcyclohexenone and diarylindazole derivatives as tubulin polymerization inhibitors
by: Riham I. Ahmed, et al.
Published: (2017-01-01)

Second-Generation Antimitotics in Cancer Clinical Trials
by: Pedro Novais, et al.
Published: (2021-07-01)

Methoxy and bromo scans on N-(5-methoxyphenyl) methoxybenzenesulphonamides reveal potent cytotoxic compounds, especially against the human breast adenocarcinoma MCF7 cell line
by: Myriam González, et al.
Published: (2021-01-01)

Natural products as new antimitotic compounds for anticancer drug development
by: Carlos Roberto Koscky Paier, et al.
Published: (2018-12-01)

Synthesis and antitumor activity of litseaone B analogues as tubulin polymerisation inhibitors
by: Wei Yang, et al.
Published: (2022-12-01)

Antiproliferative and Tubulin-Destabilising Effects of 3-(Prop-1-en-2-yl)azetidin-2-Ones and Related Compounds in MCF-7 and MDA-MB-231 Breast Cancer Cells
by: Shu Wang, et al.
Published: (2023-07-01)

In vitro antimitotic and cytotoxic potential of plant extracts: a comparative study of Mucuna pruriens, Asteracantha longifolia and Sphaeranthus indicus
by: Praveen Suresh Gupta, et al.
Published: (2020-12-01)

Potent Quinoline-Containing Combretastatin A-4 Analogues: Design, Synthesis, Antiproliferative, and Anti-Tubulin Activity
by: Tarek S. Ibrahim, et al.
Published: (2020-11-01)

Synthesis, biological evaluation and molecular docking investigation of new sulphonamide derivatives bearing naphthalene moiety as potent tubulin polymerisation inhibitors
by: Guangcheng Wang, et al.
Published: (2021-01-01)

Cytotoxic substituted indolizines as new colchicine site tubulin polymerisation inhibitors
by: Monica-Cornelia Sardaru, et al.
Published: (2020-01-01)

Re-investigating PLK1 inhibitors as antimitotic agents
by: Quentin Delacour, et al.
Published: (2017-11-01)

Kojic Acid Derivative as an Antimitotic Agent That Selectively Kills Tumour Cells
by: Giuseppina Pichiri, et al.
Published: (2024-12-01)

Chromosome doubling effects of selected antimitotic agents in Brassica napus microspore culture
by: Miroslav Klíma, et al.
Published: (2008-03-01)

Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation
by: Mohamed Hagras, et al.
Published: (2021-01-01)

Prenylated Chalcone 2 Acts as an Antimitotic Agent and Enhances the Chemosensitivity of Tumor Cells to Paclitaxel
by: Joana Fonseca, et al.
Published: (2016-07-01)

Tumor-Associated Macrophages Suppress the Cytotoxic Activity of Antimitotic Agents
by: Oakley C. Olson, et al.
Published: (2017-04-01)

Antimitotic effects of <i>Cysticercus tenuicollis</i> protoscolexes extract at administration to mice and their negative consequences for organism
by: T. S. Novik, et al.
Published: (2023-04-01)

Antiproliferative benzothiazoles incorporating a trimethoxyphenyl scaffold as novel colchicine site tubulin polymerisation inhibitors
by: Dong-Jun Fu, et al.
Published: (2020-01-01)

Anticancer sulfonamide hybrids that inhibit bladder cancer cells growth and migration as tubulin polymerisation inhibitors
by: Jia Liu, et al.
Published: (2019-01-01)

PGV-1 is a potent antimitotic agent
by: Barinta Widaryanti, et al.
Published: (2008-07-01)

Antiproliferative Activity and Molecular Docking of Novel Double-Modified Colchicine Derivatives
by: Urszula Majcher, et al.
Published: (2018-11-01)

Novel Selective Estrogen Receptor Ligand Conjugates Incorporating Endoxifen-Combretastatin and Cyclofenil-Combretastatin Hybrid Scaffolds: Synthesis and Biochemical Evaluation
by: Patrick M. Kelly, et al.
Published: (2017-08-01)

Bioassay-Guided Fractination of Antimitotic Compound from Ongkea Cortex (Mezzettia parviflora Becc) Towards Sea Urchin Eggs
by: Muh. Akbar Bahar, et al.
Published: (2015-06-01)

Tertiary sulphonamide derivatives as dual acting small molecules that inhibit LSD1 and suppress tubulin polymerisation against liver cancer
by: Lijuan Ding, et al.
Published: (2021-01-01)

Synthesis and evaluation of anticancer activities of 2- or 4-substituted 3-(N-benzyltriazolylmethyl)-13α-oestrone derivatives
by: Rebeka Jójárt, et al.
Published: (2021-01-01)

Phytochemical screening and antioxidant, antimitotic, and antiproliferative activities of Trichodesma indicum shoot
by: Shweta S Saboo, et al.
Published: (2014-01-01)

ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells
by: Ricardo Parrondo, et al.
Published: (2013-09-01)

Handbook of polymer science and technology /
by: 434742 Ferry, M. H., et al.
Published: (2004)

Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review
by: Eavan C. McLoughlin, et al.
Published: (2020-01-01)

In Vitro and In Silico Biological Studies of 4-Phenyl-2-quinolone (4-PQ) Derivatives as Anticancer Agents
by: Yi-Fong Chen, et al.
Published: (2023-01-01)